Table 2.
Anatomopathological diagnosis of the 122 samples
| 30 Non-small-cell lung cancer | 26 colorectal cancer (23 adenocarcinoma, 2 carcinoid) |
| 13 Biliary tract cancer | 12 ovarian cancer (10 high-grade serous carcinoma, 1 germinal tumour, 1 yolk sac tumour) |
| 10 Breast cancer (9 not otherwise specified +1 breast angiosarcoma) | 7 gastric adenocarcinoma |
| 2 oesophageal cancer (1 squamous and 1 adenocarcinoma) | 2 hepatocarcinoma |
| 2 pancreatic adenocarcinoma | 2 soft tissue sarcoma (1 leiomyosarcoma and 1 liver sarcoma) |
| 1 squamous cervical cancer | 1 glioblastoma |
| 1 liver hepatoid carcinoma | 1 salivary gland tumour (parotid) |
| 1 prostate adenocarcinoma | 1 clear cell renal cell carcinoma |
| 1 squamous cell vaginal cancer |
Five colorectal samples, two cholangiocarcinoma and one cervical cancer were resent because other samples of the same tumour were available after the first failure.